Angiosarcoma of the Scalp: A Case Report and Review of Current and Novel Therapeutic Regimens

被引:12
作者
Gonzalez, Michele J. [1 ]
Koehler, Matthew M. [1 ]
Satter, Elizabeth K. [1 ]
机构
[1] Naval Med Ctr, Dept Dermatol, San Diego, CA 92134 USA
关键词
PEGYLATED-LIPOSOMAL DOXORUBICIN; CUTANEOUS ANGIOSARCOMA; KINASE INHIBITORS; SOFT-TISSUE; C-KIT; PACLITAXEL; CHEMOTHERAPY; MUTATIONS; GROWTH; HEAD;
D O I
10.1111/j.1524-4725.2009.01116.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The authors have indicated no significant interest with commercial supporters.
引用
收藏
页码:679 / 684
页数:6
相关论文
共 38 条
[1]   Treatment and outcome of 82 patients with angiosarcoma [J].
Abraham, John A. ;
Hornicek, Francis J. ;
Kaufman, Adam M. ;
Harmon, David C. ;
Springfield, Dempsey S. ;
Raskin, Kevin A. ;
Mankin, Henry J. ;
Kirsch, David G. ;
Rosenberg, Andrew E. ;
Nielsen, G. Petur ;
Desphpande, Vikram ;
Suit, Herman D. ;
DeLancy, Thomas F. ;
Yoon, Sam S. .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (06) :1953-1967
[2]   Serum concentrations of vascular endothelial growth factor-D in angiosarcoma patients [J].
Amo, Y ;
Masuzawa, M ;
Hamada, Y ;
Katsuoka, K .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (01) :160-161
[3]  
Belotti D, 1996, CLIN CANCER RES, V2, P1843
[4]   Treatment of scalp angiosarcoma by controlled perfusion of A-carotis externa with pegylated liposomal doxorubicin and intralesional application of pegylated interferon alfa [J].
Bong, AB ;
Bonnekoh, B ;
Schön, MP ;
Gollnick, H .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (02) :S20-S23
[5]  
ELIAS AD, 1989, SEMIN ONCOL, V16, P305
[6]  
FALK H, 1979, LANCET, V2, P1120
[7]  
Fata F, 1999, CANCER-AM CANCER SOC, V86, P2034, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2034::AID-CNCR21>3.3.CO
[8]  
2-G
[9]   A 14-year retrospective review of angiosarcoma: Clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy [J].
Fury, MG ;
Antonescu, CR ;
Van Zee, KJ ;
Brennan, MF ;
Maki, RG .
CANCER JOURNAL, 2005, 11 (03) :241-247
[10]  
HOLDEN CA, 1987, CANCER-AM CANCER SOC, V59, P1046, DOI 10.1002/1097-0142(19870301)59:5<1046::AID-CNCR2820590533>3.0.CO